Lucid Diagnostics Inc. (LUCD) Form 8-K — Oct 16, 2026
Lucid Diagnostics received a Nasdaq deficiency notice on October 12, 2026 because its closing bid price was below $1.00 for 30 consecutive business days through October 9, 2026. The company has until April 12, 2027 to regain compliance, which requires the closing bid price to be at least $1.00 for ten consecutive business days. A second 180-day period may be available if not cured initially.
Key figures
- Cure period days
- 180
- Minimum bid price
- $1.00
- Days below minimum
- 30 consecutive business days through October 9, 2026
- Compliance deadline
- April 12, 2027
- Required consecutive days at or above 1
- 10
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.